Last update 25 Jan 2025

AVA-001

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
AVA-001
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Recurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
Inactive Indication
B-Cell Malignant NeoplasmNon-Hodgkin Lymphoma
Originator Organization
BriSTAR Immunotech LimitedBriSTAR Immunotech LimitedStartupAvalon GloboCare Corp.Avalon GloboCare Corp.
Active Organization
Avalon GloboCare Corp.Avalon GloboCare Corp.
Inactive Organization
BriSTAR Immunotech LimitedBriSTAR Immunotech LimitedStartup
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AVA-001
NCT03952923
/ CompletedPhase 1IIT
CD19-CAR-T for Patients With B Cell Malignancies
100 Clinical Results associated with AVA-001
Login to view more data
100 Translational Medicine associated with AVA-001
Login to view more data
100 Patents (Medical) associated with AVA-001
Login to view more data
100 Deals associated with AVA-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Hodgkin LymphomaPhase 1
CN
Avalon GloboCare Corp.Avalon GloboCare Corp.
19 Sep 2019
Precursor B-Cell Lymphoblastic Leukemia-LymphomaPhase 1
CN
Avalon GloboCare Corp.Avalon GloboCare Corp.
19 Sep 2019
B-Cell Malignant NeoplasmPhase 1
CN
BriSTAR Immunotech LimitedBriSTAR Immunotech LimitedStartup
01 Aug 2019
B-Cell Malignant NeoplasmPhase 1
CN
Avalon GloboCare Corp.Avalon GloboCare Corp.
01 Aug 2019
Recurrent B Acute Lymphoblastic LeukemiaPhase 1
CN
Avalon GloboCare Corp.Avalon GloboCare Corp.
15 Jul 2019
Refractory B Acute Lymphoblastic LeukemiaPhase 1
CN
Avalon GloboCare Corp.Avalon GloboCare Corp.
15 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free